A detailed history of Summa Corp. transactions in Abbott Laboratories stock. As of the latest transaction made, Summa Corp. holds 2,213 shares of ABT stock, worth $253,963. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,213
Previous 2,213 -0.0%
Holding current value
$253,963
Previous $230 Million 9.72%
% of portfolio
0.12%
Previous 0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $242,367 - $267,684
2,213 New
2,213 $252 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Summa Corp. Portfolio

Follow Summa Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summa Corp., based on Form 13F filings with the SEC.

News

Stay updated on Summa Corp. with notifications on news.